Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009794HBVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS10036366HBVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058841HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058842HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058843HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058844HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058845HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058846HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058847HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058848HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TCGA Plot Options
Drug Information
GeneBCHE
DrugBank IDDB00733
Drug NamePralidoxime
Target IDBE0002180
UniProt IDP06276
Regulation Typeactivator
PubMed IDs18825528; 11393267
CitationsPohanka M, Jun D, Kuca K: In vitro reactivation of trichlorfon-inhibited butyrylcholinesterase using HI-6, obidoxime, pralidoxime and K048. J Enzyme Inhib Med Chem. 2009 Jun;24(3):680-3. doi: 10.1080/14756360802328315.@@Khan S, Hemalatha R, Jeyaseelan L, Oommen A, Zachariah A: Neuroparalysis and oxime efficacy in organophosphate poisoning: a study of butyrylcholinesterase. Hum Exp Toxicol. 2001 Apr;20(4):169-74.
GroupsApproved; Vet_approved
Direct ClassificationN-methylpyridinium compounds
SMILESC[N+]1=C(C=NO)C=CC=C1
Pathways
PharmGKBPA164744926
ChEMBLCHEMBL1420